The Strategy Behind a Proof of Concept Clinical Trial: Balancing Science, Logistics, Economics, and the FDA
Jul 23 2014
Buchanan Ingersoll & Rooney
One America Plaza, San Diego, CA
One America Plaza, San Diego, CA
Buchanan Ingersoll & Rooney is proud to sponsor Integrium Clinical Research’s breakfast seminar, “The Strategy Behind a Proof of Concept Clinical Trial: Balancing Science, Logistics, Economics, and the FDA,” on Wednesday, July 23.
Integrium is a full-service clinical research organization (CRO) specializing in Proof of Concept clinical trials. Integrium focuses on research in the therapeutic areas of cardiovascular disease, metabolic disease, dermatology, endocrinology, renal and central nervous system. Integrium also owns a 50+ bed PK Unit, Phase II-IV clinics, and Integrium South Africa, making its business structure unique to the industry.
Integrium is a full-service clinical research organization (CRO) specializing in Proof of Concept clinical trials. Integrium focuses on research in the therapeutic areas of cardiovascular disease, metabolic disease, dermatology, endocrinology, renal and central nervous system. Integrium also owns a 50+ bed PK Unit, Phase II-IV clinics, and Integrium South Africa, making its business structure unique to the industry.
Related Services & Industries
Related Offices